Pethealth Inc. Consolidated Financial Statements. December 31, 2011

Consolidated Financial Statements,

To the Shareholders of Pethealth Inc. KPMG LLP Telephone (416) 777-8500 Chartered Accountants Fax (416) 777-8818 Bay Adelaide Centre Internet www.kpmg.ca 333 Bay Street Suite 4600 Toronto ON M5H 2S5 Canada INDEPENDENT AUDITORS' REPORT We have audited the accompanying consolidated financial statements of Pethealth Inc., which comprise the consolidated statements of financial position as at,,, and January 1,, the consolidated statements of income, comprehensive income, changes in equity and cash flows for the years ended, and,, and notes, comprising a summary of significant accounting policies and other explanatory information. Management's Responsibility for the Consolidated Financial Statements Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with International Financial Reporting Standards, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error. Auditors' Responsibility Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with Canadian generally accepted auditing standards. Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement. An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the entity's preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity's internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that the audit evidence we have obtained in our audits is sufficient and appropriate to provide a basis for our audit opinion. Opinion In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of Pethealth Inc. as at,,, and January 1,, and its consolidated financial performance and its consolidated cash flows for the years ended, and, in accordance with International Financial Reporting Standards. Chartered Accountants, Licensed Public Accountants March 7, 2012 Toronto, Canada KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ( KPMG International ), a Swiss entity. KPMG Canada provides services to KPMG LLP.

Consolidated statements of financial position (in thousands) Notes January 1 Assets Cash and cash equivalents 4 5,828 5,082 7,310 Segregated cash 5 4,872 4,193 3,489 Trade and other receivables 6 1,336 985 2,245 Inventory 7 196 154 522 Prepaid and other current assets 903 766 714 Total current assets 13,135 11,180 14,280 Notes receivable 8 1,520 1,475 1,437 Property and equipment 9 946 1,039 1,074 Goodwill 10 3,649 3,584 3,905 Intangible assets 11 8,527 7,417 6,079 Deferred income taxes 13 209 Total non current assets 14,642 13,724 12,495 Total assets 27,777 24,904 26,775 Liabilities Trade and other payables 12 4,082 3,093 3,744 Income taxes payable 482 Due to insurance carriers 5 4,872 4,193 3,489 Unearned revenue 322 193 218 Loans and borrowings 14 124 1,769 2,681 Total current liabilities 9,400 9,248 10,614 Loans and borrowings 14 62 142 1,908 Deferred income taxes 13 194 Total non current liabilities 256 142 1,908 Total liabilities 9,656 9,390 12,522 Shareholders Equity Share capital 15 14,497 14,497 14,450 Contributed surplus 1,936 1,719 1,610 Accumulated other comprehensive income (535) (708) Retained earnings (deficit) 2,223 6 (1,807) Total shareholders equity attributable to equity holders of the Company 18,121 15,514 14,253 Total liabilities and shareholders equity 27,777 24,904 26,775 (Notes on pages 5 to 48 are an integral part of these consolidated financial statements) On behalf of the Board: Richard Renaud David Atkins Director Director 1

Consolidated income statements (in thousands, except for EPS) Notes Year ended Revenue Insurance commissions and fees 22,263 23,430 Microchip technology and non insurance revenue 10,911 8,778 Other income 30 Revenue 33,204 32,208 Cost of goods sold 5,518 4,630 Selling and marketing 10,800 12,413 Administrative 13,508 13,087 Foreign currency translation loss(gain) 160 (30) Expenses 16 29,986 30,100 Results from operating activities 3,218 2,108 Finance revenue 69 54 Finance costs (28) (159) Net finance revenue(costs) 17 41 (105) Profit before income tax 3,259 2,003 Income tax expense(recovery) 13 432 (420) Profit for the period 2,827 2,423 Earnings per share 18 Basic earnings per share 0.07 0.06 Diluted earnings per share 0.06 0.05 Pethealth Inc. Consolidated statement of comprehensive income (in thousands, except for EPS) Year ended Profit for the period 2,827 2,423 Other comprehensive income (loss), net of income taxes: Foreign currency translation gain(loss) from foreign 173 (708) operations Total comprehensive income for the period, net of income taxes 3,000 1,715 (Notes on pages 5 to 48 are an integral part of these consolidated financial statements) 2

Consolidated statements of cash flows (in thousands) Year ended Notes Cash flows from operating activities Profit for the period 2,827 2,423 Adjustments for: Depreciation 9 231 259 Amortisation of intangible assets 11 1,642 1,423 Net finance costs 17 (41) 105 Deferred income taxes 13.1 403 (209) Foreign exchange movements (37) (113) Share based payment transactions 217 109 5,242 3,997 Changes in: Trade and other receivables (280) 1,178 Inventories (39) 364 Prepaid and other current assets (122) (72) Trade and other payables 767 (75) Income taxes payable/(recoverable) (213) Unearned revenue 120 (22) Cash flows from operating activities 5,688 5,157 Interest paid 17 (28) (159) Income tax recovered 189 Income tax paid (52) (466) Net cash from operating activities 5,797 4,532 Cash flows from investing activities Purchase of intangible assets (2,722) (2,881) Purchase of property and equipment (79) (158) Interest received 17 24 16 Net cash from investing activities (2,777) (3,023) Cash flows from financing activities Issuance of common shares, on exercise of options 51 Additional share issue cost (4) Repayment of loans and borrowings (1,746) (2,678) Dividend and tax on preferred shares paid (610) (610) Net cash from financing activities (2,356) (3,241) Net increase(decrease) in cash and cash equivalents 664 (1,732) Unrestricted cash and cash equivalents at beginning of year 5,082 7,310 Effect of exchange rate fluctuations on cash held 82 (496) Unrestricted cash and cash equivalents at end of year 4 5,828 5,082 Memo note: (in thousands) Year ended Segregated cash at beginning of year 4,193 3,489 Change during the period 679 704 Segregated cash at end of year 4,872 4,193 3

Consolidated statement of changes in equity (in thousands) Year ended, Share capital Contributed Surplus Translation reserve Retained earnings (deficit) Total Equity Balance at January 1, 14,497 1,719 (708) 6 15,514 Total comprehensive income for the year Profit for the year - 2,827 2,827 Other comprehensive income: Foreign currency translation differences 173 173 Total other comprehensive income 173-173 Total comprehensive income for the year 173 2,827 3,000 Transactions with owners of the company, recorded directly in equity Dividends paid to equity holders (610) (610) (including tax of $25) Share based payment transactions 217 217 Total transactions with owners of the Company 217 (610) (393) Balance at, 14,497 1,936 (535) 2,223 18,121 Year ended, Balance at January 1, 14,450 1,610 (1,807) 14,253 Total comprehensive income for the year Profit for the period - 2,423 2,423 Other comprehensive income: Foreign currency translation differences (708) (708) Total other comprehensive income (708) (708) Total comprehensive income for the year (708) 2,423 1,715 Transactions with owners of the company, recorded directly in equity Issuance of common shares Dividends paid to equity holders (610) (610) (including tax of $25) Share based payment transactions 109 109 Share options exercised 47 47 Total transactions with owners of the Company 47 109 (610) (454) Balance at, 14,497 1,719 (708) 6 15,514 4

Year ended, and, 1. Nature of operations and general information The consolidated financial statements of the Company for the twelve months ended, include the accounts of the Company and its subsidiaries (together referred to as the Company ). The Company, domiciled in Canada with its head office at 710 Dorval Drive, Oakville, Ontario is a leading provider of companion animal services and the second largest provider of medical insurance for dogs and cats to pet owners in North America, operating in Canada, the United States and the United Kingdom. The Company offers a unique range of products and services for veterinarians, animal welfare organizations, and pet owners. In addition, the Company is the leading provider of management software to North American animal welfare organizations through its cloud based application PetPoint. As a cloud based application, PetPoint provides exclusive data management and reporting capabilities to licensed organizations while at the same time significantly reducing, if not eliminating, their IT related infrastructural costs. The Company is also the leading provider of pet recovery database management services to the North American companion animal industry under the brand 24PetWatch. Early in, the Company introduced its pet recovery database services in the U.K. market under its petprotect brand. Petango.com, launched in 2009, is the only adoptable pet search site that exclusively publishes pets available for adoption with a real time live feed powered by PetPoint. The Petango brand has evolved from an adoptable search portal to an online destination for pet lovers to learn about pets, search for pets, engage with other pet lovers as well as purchase pet supplies and medications through ThePetangoStore.com. These consolidated financial statements were approved by the Board of Directors on March 7, 2012. 2. Statement of compliance (a) Statement of Compliance These consolidated financial statements were prepared in accordance with International Financial Reporting Standards ("IFRSs"), as issued by the International Accounting Standards Board ("IASB"). These are the Company s first annual financial statements prepared in accordance with IFRS and IFRS I First Time Adoption of International Financial Reporting Standards has been applied. An explanation of how the transition to IFRS has affected the reported financial position, financial performance and cash flows of the Company is provided in note 22. This note includes reconciliations of equity, profit and total comprehensive income for the comparative year,, and of equity at the date of transition January 1,, reported under Canadian GAAP ( previous GAAP ) to those reported under IFRS. 5

Year ended, and, (b) Basis of Measurement The consolidated financial statements have been prepared on the historical cost basis except for liabilities for cash settled share based payment arrangements, which are measured at fair value. (c) Functional Currency These consolidated financial statements are presented in Canadian dollars, which is the Company s functional currency. All financial information presented has been rounded to the nearest thousand except Earnings per Share ( EPS ) and as otherwise noted. (d) Use of Estimates and Judgements The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amount of assets, liabilities, income and expenses. Actual results may differ materially from these estimates. In preparing these consolidated financial statements, the significant judgements made by management in applying the Company s accounting policies and the key sources of estimation uncertainty are as follows: (i) Judgement The key judgement made in applying accounting policies that has the most significant effect on the amounts recognised in these consolidated financial statements is as follows: Non Monetary Commission Revenue Certain commission revenue is related to pet insurance policies sold to arm's length animal welfare organisations in exchange for certain distribution and advertising services. This non monetary commission revenue and the related marketing expenses are recorded on a gross basis. In determining whether to present these transactions on a gross or net basis, management considered whether or not the exchange of products and services was similar in nature and concluded that the sale of pet insurance policies and the provision of distribution and advertising services was dissimilar. (ii) Use of Estimates Information about the assumptions and estimation uncertainties that have a significant risk of resulting in a material adjustment within the next twelve months are as follows: Valuation of Goodwill Goodwill is assessed for impairment at the Cash Generating Unit ( CGU ) level on an annual basis and more frequently if there are potential indicators of impairment. An impairment loss is recognized if the carrying value of a CGU exceeds its recoverable amount. 6

Year ended, and, The recoverable amount of a CGU is determined from the greater of fair value or value in use calculations based on the net present value of discounted cash flow. Key assumptions used in the calculation of recoverable amounts are future revenues, discount rates, terminal value growth rates and corporate overhead costs. See note 10 for details in respect of the calculation of the recoverable amount of PetProtect Limited CGU. Income Tax, Deferred Tax and the Utilization of Tax Losses Deferred tax assets and liabilities require management s judgement in determining the amount to be recognized. In particular, judgement is used when assessing the extent to which deferred tax assets should be recognized with consideration to the timing and level of future taxable income. The Company assesses its deferred income tax asset on a quarterly basis. The actual income tax for the year is determined according to complex tax laws and regulations. Where the effect of these laws and regulations is unclear, estimates are used in determining the tax liability for tax to be paid on past profits which are recognized in the financial statements. The Company considers estimates, assumptions and judgements to be reasonable but this can involve complex issues which may take a number of years to resolve. The final determination of prior year tax liabilities could be different from the estimates reflected in the financial statements. 3. Summary of significant accounting policies The accounting policies set out below have been applied consistently to all the periods presented in these consolidated financial statements and in preparing the opening IFRS statement of financial position at January 1, for the purposes of the transition to IFRS, unless otherwise indicated. 3.1 Basis of Consolidation The consolidated financial statements comprise the financial statements of Pethealth Inc. and its subsidiaries. The financial statements of the subsidiaries are prepared for the same reporting periods, using consistent accounting policies. Subsidiaries are all entities over which the Company has the power to control the financial and operating policies, generally accompanying a shareholding of more than one half the voting rights. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and will continue to be consolidated until control ceases. All of Pethealth s subsidiaries are wholly owned. 3.1.1 Business Combinations Acquisitions prior to January 1, As part of its transition to IFRS the Company elected not to restate those business combinations that occurred prior to January 1,. In respect of acquisitions prior to January 1,, goodwill represents the amount recognised under the Company s previous accounting framework, Canadian GAAP. 7

Year ended, and, 3.1.2 Transactions Eliminated on Consolidation Inter company transactions, balances and unrealised gains or losses on intra group transactions are eliminated upon consolidation. 3.2 Segmented reporting An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company s other components. All operating segments operating results are reviewed regularly by the Company s management to make decisions about resources to be allocated to the segment and to assess its performance, and for which discrete financial information is available. Segment results that are reported to the Company s management include items that are directly attributable to a segment as well as those that can be allocated on a reasonable basis. Segment capital expenditures are the total cost incurred during the period to acquire property and equipment, and intangible assets other than goodwill. 3.3 Foreign currency 3.3.1 Foreign currency transactions Transactions in foreign currencies are translated to the respective functional currency of Company entities at exchange rates at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are retranslated to the functional currency at the exchange rate at that date. The foreign currency gain or loss on monetary items is the difference between the amortised cost in the functional currency at the beginning of the period, adjusted for effective interest and payments during the period, and the amortised cost in foreign currency translated at the exchange rate at the end of the period. Non monetary assets and liabilities denominated in foreign currencies that are measured at fair value are retranslated to the functional currency at the exchange rate at the date that the fair value was determined. Non monetary items in a foreign currency that are measured at historical cost are translated using the exchange rate at the date of the transaction. Foreign currency differences arising on translation are recognised in the consolidated income statement. 3.3.2 Foreign Operations The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are translated to Canadian dollars at exchange rates at the reporting date. The income and expenses of foreign operations are translated to Canadian dollars at exchange rates at the dates of the transactions. 8

Year ended, and, Since January 1,, the Company s date of transition to IFRS, foreign currency differences are recognised and presented in other comprehensive income and in the foreign currency translation reserve (translation reserve) in equity. When a foreign operation is disposed of such that control or significant influence is lost, the cumulative amount in the translation reserve related to that foreign operation is reclassified to profit or loss as part of the profit or loss on disposal. When the settlement of a monetary item receivable from or payable to a foreign operation is neither planned nor likely in the foreseeable future, foreign exchange gains and losses arising from such a monetary item are considered to form part of a net investment in a foreign operation and are recognised in other comprehensive income, and presented in the translation reserve in equity. 3.4 Intangible assets (a) Goodwill Goodwill relates to acquisitions prior to January 1, and is included on the basis of deemed cost, which represents the amount recorded under previous Canadian GAAP. Goodwill is measured at cost less impairment losses. (b) Other intangible assets Intangible assets that are acquired by the Company and have finite lives are measured at cost less accumulated impairment loss and are amortized over their estimated useful lives and are tested for impairment whenever changing circumstances indicate that impairment may have occurred. Amortisation is calculated from the date available for use on a straight line basis, since this most closely reflects the expected pattern of consumption of the future economic benefits embodied in the asset based on the following estimated useful lives: Contractual customer relationships Trademarks Developed software Computer software Licensing and registrations Patents Others 4 years 3 to 10 years 2 to 5 years 3 to 5 years 10 years 5 years 3 to 5 years Amortisation methods, useful lives and residual values are reviewed annually and adjusted if appropriate. (i) Contractual customer relationships acquired in a business combination are recognized at the fair value at the acquisition date. The contractual customer relations have a finite useful life and are carried at cost less accumulated amortisation. Amortisation is calculated using the straight line method over the expected life of the customer relationships. 9

Year ended, and, (ii) Trademarks, licenses and patents Separately acquired trademarks, licenses and patents are recorded initially at historical cost. Trademarks and licenses acquired in a business combination are recognized at the fair value at the acquisition date. The trademarks, licenses and patents have a finite useful life and are carried at cost less accumulated amortisation. Amortisation is calculated using the straight line method over their estimated useful life. (iii) Computer and internally developed software Acquired computer software licenses are capitalized on the basis of the costs incurred to acquire and bring to use the specific software. Costs associated with maintaining computer software programmes are recognized as an expense as incurred. Development costs that are directly attributable to the design and testing of identifiable unique software products controlled by the Company are recognized as intangible assets when the following criteria are met: it is technically feasible to complete the software product so that it will be available for use or sale; management intends to complete the software product and use or sell it; there is an ability to use or sell the software product; it can be demonstrated how the software product will generate future probable future economic benefits; adequate technical, financial and other resources to complete the development and to use or sell it, are available; the expenditures attributable to the software product during its development can be reliably measured. Costs that are capitalized as part of the software include cost of materials, direct labour and overhead costs that are directly attributable to preparing the asset for its intended use. Capitalized development software is measured at cost less accumulated amortisation and accumulated impairment losses. Amortisation of developed software begins when the asset is available for use and capable of operating in the manner intended by management. Borrowing costs that are not directly attributable to the acquisition, construction or production of a qualifying asset are recognised in profit or loss using the effective interest method. A qualifying asset is an asset that necessarily takes a substantial period of time to get ready for its intended use. The Company capitalizes borrowing costs incurred on or after January 1, for certain of its internally generated intangible assets. Other development expenditures which do not meet the above criteria are recognized as an expense when incurred. The Company does not have any indefinite life intangible assets. 10

Year ended, and, 3.5 Property and Equipment Recognition and Measurement Items of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. Costs includes expenditures that are directly attributable to the acquisition of the asset including any borrowing costs on qualifying assets for which the commencement date for capitalisation is on or after January 1,. Gains or losses on the disposal of an item of property and equipment are determined by comparing the proceeds from disposal with the carrying amount of the property and equipment, and are recognised net within the statement of income. Subsequent Costs The cost of replacing a component of an item of property and equipment is recognised in the carrying amount of the item if it is probable that the future economic benefits embodied within the component will flow to the Company, and its cost can be measured reliably. The carrying amount of the replaced component is derecognized. The costs of day to day servicing of property and equipment are recognised in the consolidated income statement as incurred. Depreciation Depreciation is based on the cost of an asset less its residual value. Depreciation is recognised in the consolidated income statement over the estimated useful life of each item of property and equipment as set out below. Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Method Rate Furniture and fixtures Declining balance 20% Computer hardware Declining balance 30% Office equipment Declining balance 30% Leasehold improvements Declining balance 30% The residual values, useful lives and depreciation methods of items of property and equipment are reviewed, and adjusted if appropriate, at each annual reporting date. 3.6 Financial Instruments The Company has financial assets and liabilities consisting of cash and cash equivalents, segregated cash, trade and other receivables, notes receivable, trade and other payables, due to insurance carriers and loans and borrowings. The Company classifies its non derivative financial assets as loans and receivables. Loans and receivables are non derivative financial assets or liabilities with fixed or determinable payments that are not quoted in an active market. They are included in current assets or 11

Year ended, and, liabilities, except for settlements due greater than 12 months after the consolidated balance sheet date which are classified as non current assets or liabilities. The Company's financial assets and liabilities are recorded at their cost, or amortised cost when interest bearing, which approximates their fair value. Non derivative Financial Assets The Company initially recognises loans and receivables and deposits on the date that they are originated. All other financial assets are recognised initially on the trade date at which the Company becomes a party to the contractual provisions of the instrument. The Company derecognises a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the rights to receive the contractual cash flows on the financial asset in a transaction in which substantially all the risks and rewards of ownership of the financial asset are transferred. Any interest in transferred financial assets that is created or retained by the Company is recognised as a separate asset or liability. Financial assets and liabilities are offset and the net amount presented in a statement of financial position when, and only when, the Company has a legal right to offset the amounts and intends either to settle on a new basis or to realise the asset and settle the liability simultaneously. Cash and Cash Equivalents Cash and cash equivalents comprise cash balances with original maturities of three months or less. Loans and Receivables Loans and receivables comprise trade and other receivables, and notes receivables which are financial assets with fixed or determinable payments that are not quoted in an active market. Such assets are recognised initially at fair value plus any directly attributable transaction costs. Subsequent to initial recognition loans and receivables are measured at amortised cost using the effective interest method, less any impairment losses. Non derivative Financial Liabilities The Company initially recognises debt securities issued on the date that they are originated. All other financial liabilities are recognised initially on the trade date at which the Company becomes a party to the contractual provisions of the instrument. The Company derecognises a financial liability when its contractual obligations are discharged or cancelled or expire. The Company classifies non derivative financial liabilities into the other financial liabilities category. Such financial liabilities are recognised initially at fair value plus any directly attributable transaction costs. Subsequent to initial recognition, these financial liabilities are measured at amortised cost using the effective interest method. Other financial liabilities comprise loans and borrowings, trade and other payables, and due to insurance carriers. 12

Year ended, and, Trade and other payables Trade and other payables are obligations to pay for goods and services that have been acquired in the normal course of business from suppliers. Other payables are classified as current liabilities if payment is due within one year or less. Loans and borrowings Borrowings are recognized initially at fair value, net of transaction costs incurred, and are subsequently amortized to their maturity using the effective interest rate method. 3.7 Inventories Inventories are measured at the lower of cost, including direct expenditures plus other attributable costs incurred in bringing inventories to their current location and condition, and net realizable value. Cost is determined using the first in, first out (FIFO) method. Net realizable value is the estimated selling price in the normal course of business, less the estimated costs of selling expenses. 3.8 Impairment Non derivative Financial Assets A financial asset not carried at fair value through profit or loss is assessed at each reporting date to determine whether there is objective evidence that it is impaired. A financial asset is impaired if objective evidence indicates that a loss event has occurred after the initial recognition of the asset, and that the loss event had a negative effect on the estimated future cash flows of that asset that can be estimated reliably. Objective evidence that financial assets are impaired can include default or delinquency by a debtor, restructuring of an amount due to the Company on terms that the Company would not consider otherwise, indications that a debtor or issuer will enter bankruptcy, adverse changes in the payment status of borrowers or issuers in the Company and economic conditions that correlate with defaults. Loans and Receivables The Company considers evidence of impairment for loans and receivables at both a specific asset and collective level. All individually significant loans and receivables are assessed for specific impairment. All individually significant loans and receivables found not to be specifically impaired are then collectively assessed for any impairment that has been incurred but not yet identified. Loans and receivables that are not individually significant are collectively assessed for impairment by grouping together receivables with similar risk characteristics. 13

Year ended, and, In assessing collective impairment the Company uses historical trends of the probability of default, the timing of recoveries and the amount of loss incurred, adjusted for management s judgement as to whether current economic and credit conditions are such that the actual losses are likely to be greater or less than suggested by historical trends. An impairment loss in respect of a financial asset measured at amortised cost is calculated as the difference between its carrying amount and the present value of the estimated future cash flows discounted at the asset s original effective interest rate. Losses are recognised in profit or loss and reflected in an allowance account against loans and receivables. When a subsequent event (e.g. repayment by a debtor) causes the amount of impairment loss to decrease, the decrease in impairment loss is reversed through the consolidated income statement. Non financial Assets The carrying amounts of the Company s non financial assets other than inventories and deferred tax assets, being property and equipment and intangible assets, are reviewed at each annual reporting date to determine whether there is any indication of impairment. If any such indication exists, then the asset s recoverable amount is estimated. For goodwill and intangible assets that have an indefinite useful life, the recoverable amount is estimated each period at the same time. An impairment loss is recognised if the carrying amount of an asset or its related cash generating unit ( CGU ) exceeds its estimated recoverable amount. Goodwill is allocated to CGUs for the purposes of impairment testing. The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs to sell. In assessing value in use, the estimated future cash flows after allocating corporate assets are discounted to their present value using a pre tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset or CGU. For the purpose of impairment testing, assets that cannot be tested individually are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or CGUs. Subject to an operating segment ceiling test, for the purposes of goodwill impairment testing, CGUs to which goodwill has been allocated are aggregated so that the level at which impairment testing is performed reflects the lowest level at which goodwill is monitored for internal reporting purposes. Goodwill acquired in a business combination is allocated to groups of CGUs that are expected to benefit from the synergies of the combination. Impairment losses are recognised in the consolidated income statement. Impairment losses recognised in respect of CGUs are allocated first to reduce the carrying amount of any goodwill allocated to the CGU (group of GCUs), and then to reduce the carrying amounts of the other assets in the CGU (group of CGUs) on a pro rata basis. The determination of gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold. An impairment loss in respect of goodwill is not reversed. In respect of other assets, impairment losses recognised in prior periods are assessed at each annual reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortisation, if no impairment loss had been recognised. 14

Year ended, and, 3.9 Provisions A provision is recognised if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future cash flows at a pre tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognised as a finance cost. 3.10 Revenue recognition Revenue comprises the fair value of the consideration received or receivable for the sale of goods and services in the normal course of the Company s activities. Revenue is shown net of sales taxes. The Company recognises revenue when persuasive evidence exists that the significant risks and rewards of ownership have been transferred and when the amount of revenue can be reliably measured and when specific criteria have been met as described below. Insurance Segment Revenue Commission revenue relates to the sale and/or renewal of pet insurance policies in which the Company acts as agent in the transaction rather than principal. The Company is licensed as an insurance agent / broker in the jurisdictions in which it operates. Other than a limited participation in the underwriting results for core policies sold in the United States and the United Kingdom, the underwriting risk associated with the pet insurance policies sold is borne entirely by the Company s licensed insurance carriers. Revenue from commissions is derived from the sale of insurance policies which premiums are billed principally on a monthly basis. Base commissions are recognised as revenue on the effective dates of the related monthly insurance premiums, except for annually billed policies which are recognised, net of mid term cancellation reserves as revenue on the policies' effective, renewal or anniversary dates. Commission adjustments, related to the Company s limited participation in underwriting results, are made quarterly. The Company earns commission revenue through the sale of certain pet insurance policies to arm's length animal welfare organisations which in turn charge the Company a related fee for access to their distribution network, as well as advertising to pet owners adopting pets from their organisation. Revenue and expenses are recorded based on the fair value of the services provided by the Company for similar cash transactions. Non Insurance Segment Revenues Revenue, net of returns, from the sale of microchips and microchip readers is recorded when the goods are shipped. Revenue from the retail sale of products from the Company s e commerce site is recognised when the goods are shipped. A provision is made for returns based on historical trends. 15

Year ended, and, Administration fees are non refundable and are recorded as revenue over the period in which administration services are provided. Unearned administration fees are deferred and recognised as revenue as administrative services are provided. Database and data revenue is recognised either over the period in which the service is provided or, where long term contracts require the performance of more than one service, proportionately by reference to the performance of each service to the extent each has stand alone value. 3.11 Leases Leases in which a significant portion of the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under the operating leases are charged to the consolidated income statement on a straight line basis over the period of the lease. The Company leases certain property and equipment. Leases of property and equipment where the Company has substantially all the risks and rewards are classified as finance leases. Finance leases are capitalized at the lease s commencement at the lower of the fair value of the leased property and the present value of the minimum lease payments. Subsequent to the initial recognition, the asset is accounted for in accordance with the accounting policy applicable to the asset. Lease payments made under finance leases are apportioned between the finance expense and the reduction of the outstanding liability. The finance expense is allocated to each period during the lease term so as to produce a constant periodic rate of interest on the remaining balance of the liability. 3.12 Income tax Income tax expense comprises current and deferred tax. Current tax and deferred tax is recognised in profit or loss except to the extent that it relates to a business combination, or items recognised directly in equity or in other comprehensive income. Current tax is the expected tax payable or receivable on the taxable income or loss for the period, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Current tax payable also includes any tax liability arising from the declaration of dividends. Deferred tax is recognised in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognised for: Temporary differences on the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss; Temporary differences related to investments in subsidiaries to the extent that it is probable that they will not reverse in the foreseeable future; and Taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date. 16

Year ended, and, Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realised simultaneously. A deferred tax asset is recognised for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilised. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is not probable that the related tax benefit will be realised. 3.13 Share Capital Common shares are classified as equity. Incremental costs directly attributable to the issue of common shares or options are shown as a deduction from equity, net of taxes. Preference share capital is classified as equity if it is non redeemable, or redeemable only at the Company s option, and any dividends are discretionary. Dividends theron are recognised as distributions within equity upon approval by the Company s Board. 3.14 Employee Costs Defined contribution plans A defined contribution plan is a post employment benefit plan under which an entity pays fixed contributions into a separate entity and will have no legal or constructive obligation to pay further amounts. Obligations for contributions to defined contribution pension plans are recognised as an employee benefit expense in the periods during which services are rendered by employees. Short term employee benefits Short term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service is provided. A liability is recognised for the amount expected to be paid under short term cash bonus plans if the Company has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated reliably. Stock options The Company operates an equity settled, share based stock option plan for employees and directors. Under the equity settled share plan, the Company receives services from employees as consideration for share options of the Company. The fair value of the employee services received in exchange for the grant of options is recognized as an expense. The total amount to be expensed over the vesting period is determined by reference to the fair value of options granted as calculated using the Black Scholes option pricing model and an estimate of forfeiture rates prior to vesting. The Black Scholes model requires judgements to be made regarding expected volatility, dividend yield, risk free rates of return and expected option lives. Forfeiture rates are 17

Year ended, and, based on past experience and are adjusted if subsequent information indicates that the actual forfeitures are likely to differ from the estimate. Share unit plan for directors The Company operates a share unit plan for directors. The fair value of this plan is calculated on each statement of financial position date and the appreciation or depreciation in value is recorded as compensation expense with the counterpart in trade and other payables on the consolidated statement of financial position. 3.15 Finance Income and Finance Costs Interest income consists of interest earned from short term investments, consisting of guaranteed investment certificates and notes receivable and is recognised in finance income. Interest income is recognised as it accrues in the consolidated income statement, using the effective interest method. Finance costs comprise interest expense on borrowings and impairment losses recognised on financial assets (other than trade receivables). 3.16 Earnings per Share The Company presents basic and diluted earnings per share data for its common shares. Basic earnings per share is calculated by dividing the profit or loss attributable to the common shareholders of the Company by the weighted average number of common shares outstanding during the period, adjusted for own shares held. Diluted earnings per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding, adjusted for own shares held, for the effects of all dilutive potential common shares, which comprise convertible preference shares, share options granted to employees and deferred share units granted to certain Company directors. 3.17 Future Accounting and Reporting Changes (i) IFRS 9 Financial instruments IFRS 9 Financial Instruments was issued in November 2009 and modifies previous standard IAS 39 Financial Instruments: Recognition and Measurement. The new standard requires financial instruments to be measured at either fair value or amortized cost. Under the new standard, the existing categories for AFS, held to maturity, and loans and receivables will be eliminated. A fair value option (fair value through income, same as held for trading (HFT)) would continue to be available on the condition that accounting mis matches are reduced. 18

Year ended, and, The new standard requires that a) embedded derivatives be assessed for classification together with their financial asset host and b) a single impairment method be used for financial assets. IFRS 9 is effective for annual periods beginning on or after January 1, 2015. The Company is currently assessing the full impact of IFRS 9 on its consolidated financial statements. (ii) IFRS 13 New Standard on Fair Value Measurement In May, the IASB published IFRS 13 Fair Value Measurement. IFRS 13 replaces the fair value measurement guidance contained in individual IFRSs with a single source of fair value measurement guidance. IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, i.e. an exit price. The standard also establishes a framework for measuring fair value and requires the fair value hierarchy, which was introduced by IFRS 7, Financial Instruments: Disclosures, to be applied to all fair value measurements, including non financial assets and liabilities that are measured at or based on fair value in the statement of financial position as well as non recurring fair value measurements such as assets held for sale. IFRS 13 expands disclosure requirements for fair value measurements to provide information that enables financial statement users to assess the methods and inputs used to develop fair value measurements. IFRS 13 is applicable prospectively for annual periods beginning on or after January 1, 2013. Earlier application is permitted with disclosure of that fact. The Company is in the process of assessing the full impact of IFRS 13 on its consolidated financial statements. (iii) IAS 17 Leases The IASB issued an exposure draft for a new standard on lease accounting for lessees and lessors that would replace IAS 17, Leases, and related interpretations. The new accounting model requires both lessees and lessors to record the assets and liabilities on the balance sheet at the present value of the lease payments arising from all lease contracts. The new classification would be the right of use model, replacing the operating and finance lease accounting models that currently exist. The final lease standard is expected to be released in 2012 at which time the Company will assess the full impact on the consolidated financial statements. 4. Cash and cash equivalents Cash and cash equivalents comprise cash, guaranteed investment certificates and short term bank deposits with an original maturity of three months or less and are held in the following currencies (those held in currencies other than Canadian dollars have been converted at the exchange rate at the statement of financial position date): 19

Year ended, and, January 1 US dollars 3,285 2,199 (96) Pounds Sterling 698 480 759 Canadian dollars 1,845 2,403 6,647 5,828 5,082 7,310 The credit risk on cash and cash equivalents is limited because the counterparties are banks with high credit ratings assigned by international credit rating agencies. The carrying amount of these assets approximates their fair value. 5. Segregated cash and due to insurance carriers Under the terms of the MGA Agreements with its insurance carriers, the Company collects premiums and pays claims on behalf of their respective insurance carriers. These funds, net of the Company s commissions, are held in trust for the benefit of the insurance carriers and cannot be used or applied for other purposes. These funds are shown on the Company s consolidated statement of financial position as segregated cash with a corresponding liability under due to insurance carriers. 6. Trade and other receivables January 1 Trade receivables 1,092 1,094 833 Less: amounts provided for doubtful accounts 68 148 87 1,024 946 746 Profit sharing Commission receivable 123 682 Other carrier receivables 761 Other receivables 189 39 56 1,336 985 2,245 Trade receivables are non interest bearing. The carrying value of trade and other receivables approximates their fair value. Trade receivables are provided for based on estimated recoverable amounts, determined by reference to past default experience. 20

Year ended, and, Aging of trade receivables is as follows: January 1 Current 720 606 450 1 60 days past due 191 284 295 60 90 days past due 39 51 33 Greater than 90 days past due 142 153 55 Movement in allowance for doubtful accounts 1,092 1,094 833 Balance at January 1 148 87 Impairment losses recognized 61 Reversal of allowance (50) Amounts written off as uncollectable (30) Balance at, and, 68 148 In determining the recoverability of a trade receivable, the Company considers any change to the credit quality of the trade receivable from the date credit was initially granted up to the reporting date. The Company has no significant exposure to credit risk, with exposure spread over a large number of customers. Trade and other receivables are held in the following currencies as at, and, with those balances held in currencies other than Canadian dollars converted at the exchange rate at the balance sheet date: US Dollars Pounds Sterling Canadian Dollars Consolidated Due within twelve months 870 98 112 1,080 Due after twelve months 12 12 As at, 882 98 112 1,092 Due within twelve months 897 96 101 1,094 Due after twelve months As at 897 96 101 1,094 7. Inventory January 1 Microchips 54 111 522 Petango Store products 142 43 196 154 522 21

Year ended, and, 8. Notes receivable and related party transactions On August 1, 2002, the Board of Directors authorized the Company to loan to the President and Chief Executive Officer the amount of $500 for the exclusive purpose of purchasing units of the Company. The loan amount was advanced by the Company and evidenced by a promissory note and a securities pledge agreement in favour of the Company for 833 Common Shares. As of August 1, 2002, these pledged shares represented a market value in excess of the loan amount of $500. The promissory note bears interest at the lesser of the prevailing Prime Rate (as hereinafter defined) and 7% per annum with a maturity date extended to January 15, 2015. Immediately following the advance of the loan, the President and Chief Executive Officer purchased 417 units of the Company at a purchase price of $1.20 per unit, each such unit consisting of a common share and a common share purchase warrant, which warrant entitled the holder thereof to acquire one common share at an exercise price of $1.00 per common share up to and including December 19, 2002. On December 19, 2002, the Board of Directors further authorized the Company to loan to the President and Chief Executive Officer an additional amount of $530 for the exclusive purpose of exercising the previously issued warrants to purchase 530 Common Shares in the capital of the Company. The loan amount was advanced by the Company and evidenced by a promissory note and a securities pledge agreement in favour of the Company for 530 Common Shares in the capital of the Company. As of December 19, 2002, these additional pledged shares represented a market value in excess of the loan amount of $530. Pursuant to this securities pledge agreement, all of the Common Shares in the capital of the Company pledged by the borrower to the Company to secure the obligations of the borrower for such loan amounts. The promissory note bears interest at the lesser of the prevailing Prime Rate and 7% per annum with a maturity date extended to January 15, 2015. Immediately following the advance of the loan by the Company, the President and Chief Executive Officer exercised the warrants and purchased an additional 530 Common Shares in the capital of the Company at an exercise price of $1.00 per warrant. For purposes of the promissory notes, Prime Rate means the per annum rate of interest from time to time quoted, published and commonly known as the prime rate of the Canadian Imperial Bank of Commerce which it establishes at its main office in Toronto, Ontario as the reference rate of interest in order to determine interest rates for loans in Canadian dollars to its Canadian borrowers, adjusted automatically with each quoted or published change in such rate, all without the necessity of any notice to the borrower or any other person. At,, the note receivable balance was $1,520 (, $1,475, January 1, $1,437). Directors and key management compensation The remuneration of the directors and members of the operating executive, who are the key management personnel of the Company, is set out below in aggregate for each of the noted categories. Year ended Employee compensation and short term benefits 750 974 Share based payments 116 578 866 1,552 22

Year ended, and, 9. Property and equipment At January 1, Furniture and fixtures Computer hardware Office equipment Leasehold improvements Cost 262 1,108 976 246 2,592 Accumulated depreciation 180 515 662 161 1,518 Net book value 82 593 314 85 1,074 Year ended, Opening net book amount 82 593 314 85 1,074 Foreign exchange differences (2) (8) (8) (2) (20) Additions 22 153 53 16 244 Depreciation charge (18) (129) (87) (25) (259) Closing net book value 84 609 272 74 1,039 At, Cost 281 1,253 1,003 259 2,796 Accumulated depreciation 197 644 731 185 1,757 Net book value 84 609 272 74 1,039 Total Year ended, Opening net book amount 84 609 272 74 1,039 Foreign exchange differences 1 1 Additions 15 116 6 137 Depreciation charge (16) (125) (71) (19) (231) Closing net book value 83 601 207 55 946 At, Cost 297 1,371 1,011 260 2,939 Accumulated depreciation 214 770 804 205 1,993 Net book value 83 601 207 55 946 Included in property and equipment is assets with a net book value of $325 held under finance leases ( $499) 10. Goodwill Balance at beginning of period 3,584 3,905 Foreign exchange differences 65 (321) Closing balance 3,649 3,584 Goodwill acquired in business combinations is allocated to the cash generating units ( CGUs ) that are expected to benefit from that business combination. The Company has defined its CGUs, for the purpose of Goodwill impairment testing, as the PetProtect insurance operation and the Canadian insurance operation including an appropriate allocation of corporate costs. 23

Year ended, and, Impairment testing for goodwill The Company tests goodwill for impairment at least annually and more regularly if there are indications that goodwill might be impaired. An impairment loss is recognized if the carrying value of a CGU exceeds its recoverable amount. The recoverable amount of a CGU is determined from the greater of fair value and value in use calculations based on the net present value of discounted cash flow. In assessing value in use, the estimated future cash flows are derived from the most recent financial budget and three year forecasts and an assumed growth rate. A terminal value is calculated by discounting using an appropriate discount rate. Impairment losses are recognized in the income statement as an expense. Management determined budgeted operating profit based on past performance and its expectations of market development. The weighted average growth rates used are consistent with the forecasts included in industry reports. The discount rate is pre tax and reflects specific risks related to the operating segment. Goodwill was tested for impairment at September 30, and there was no impairment. 11. Intangible assets Customer relationships Licensing and registrations Computer software Internally developed software Trademarks Other Total Patents At January 1, Cost 1,609 20 68 1,036 5,803 647 254 9,437 Accumulated amortisation 517 16 10 783 1,750 194 88 3,358 Net book value 1,092 4 58 253 4,053 453 166 6,079 Year ended Opening net book amount 1,092 4 58 253 4,053 453 166 6,079 Foreign exchange differences (80) (5) (1) (17) (32) (12) (147) Additions internally generated 2,443 2,443 Additions acquired 59 389 17 465 Amortisation charge (398) (4) (6) (76) (793) (87) (59) (1,423) Closing net book value 614 47 235 6,075 351 95 7,417 At Cost 1,475 20 62 1,092 8,615 626 233 12,123 Accumulated amortisation 861 20 15 857 2,540 275 138 4,706 Net book value 614 47 235 6,075 351 95 7,417 Year ended Opening net book amount 614 47 235 6,075 351 95 7,417 Foreign exchange differences 14 2 2 5 6 1 30 Additions internally generated 2,562 2,562 Additions acquired 58 87 15 160 Amortisation charge (397) (7) (69) (1,057) (65) (47) (1,642) Closing net book value 231 42 226 7,672 307 49 8,527 At Cost 1,502 20 63 1,152 11,276 649 236 14,898 Accumulated amortisation 1,271 20 21 926 3,604 342 187 6,371 Net book value 231 42 226 7,672 307 49 8,527 Additions of internally generated software include $9 (: $0) of interest capitalized at a borrowing rate of 8.5%. Included in intangible assets are assets with a net book value of $44 held under finance leases ( $133) 24

Year ended, and, 12. Trade and other payables January 1 Trade payables 2,350 1,551 2,134 Accrued professional fees 409 375 269 Provision for swing commission payable 122 226 Accrued vacation pay 168 168 178 Accrued sales partners fees 134 164 145 Deferred Share Units liability 125 107 100 Taxes and other government remittances 367 93 256 PetPoint commitment deposits 186 124 93 Other liabilities 221 285 569 4,082 3,093 3,744 Trade and other payables principally comprise amounts outstanding for trade purchases and ongoing costs. For most suppliers no interest is charged but for certain overdue balances, interest is charged at various rates. Trade and other payables are held in the following currencies (those held in currencies other than Canadian dollars have been converted at the exchange rate at the balance sheet date): US Dollars Pounds Sterling Canadian Dollars Consolidated Due within twelve months 1,799 442 1,841 4,082 As at, due within twelve months 1,799 442 1,841 4,082 Due within twelve months 1,338 332 1,423 3,093 As at, due within twelve months 1,338 332 1,423 3,093 The carrying value of trade and other payables are carried at amortised cost, which approximates their fair value. 13. Income taxes relating to continuing operations 13.1 Income tax recognised in profit or loss Current tax Current tax expense in respect of the current year 72 Adjustments recognised in the current year in relation to the current tax of prior years 29 (283) 29 (211) Deferred tax Deferred tax expense recognised in the current year 403 (209) 403 (209) Total income tax expense recognised in the current year relating to continuing operations 432 (420) 25

Year ended, and, The income tax expense for the year can be reconciled to the accounting profit as follows: Profit before tax from continuing operations 3,259 2,003 Income tax expense calculated at 28.25% ( 31%) 921 621 Effect of income that is exempt from taxation 221 Effect of expenses that are not deductible in determining taxable profit 106 (27) Effect of unused tax losses and tax offsets not recognised as deferred tax assets 31 Effect of previously unrecognised and unused tax losses and deductible temporary differences now recognised as deferred tax assets (951) (867) Effect of different tax rates of subsidiaries operating in other jurisdictions 234 65 Effect on deferred tax balances due to the change in income tax rates (54) (127) Difference between IFRS and UK or Canadian GAAP 116 (21) Other (2) 403 (137) Adjustments recognised in the current year in relation to the current tax of prior years 29 (283) Income tax expense recognised in profit or loss (relating to continuing operations) 432 (420) The tax rate used for the and reconciliations above is the corporate tax rate of 28.25% ( 31%) payable by corporate entities in Canada on taxable profits under tax law in that jurisdiction. 13.2 Current tax assets and liabilities January 1 Current tax assets Income taxes recoverable 44 213 - Current tax liabilities Income taxes payable - 482 26

Year ended, and, 13.3 Deferred tax balances The following is the analysis of deferred tax assets/(liabilities) presented in the consolidated statement of financial position: January 1 Deferred tax assets 570 217 Deferred tax liabilities (764) (8) (194) 209 Opening balance Recognised in profit or loss Closing balance Deferred tax (liabilities)/assets in relation to: Property and equipment 48 (806) (758) Intangible assets (7) 2 (6) Provisions 5 (5) Other (1) 45 (809) (764) Tax losses 164 406 570 164 406 570 209 (403) (194) Opening balance Recognised in profit or loss Closing balance Deferred tax (liabilities)/assets in relation to: Property and equipment 48 48 Intangible assets (7) (7) Provisions 5 5 Other (1) (1) 45 45 Tax losses 164 164 164 164 209 209 27

Year ended, and, 13.4 Unrecognised deductible temporary differences, unused tax losses and unused tax credits Year Ended Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognised are attributable to the following: tax losses (revenue in nature) 13,106 14,346 tax losses (capital in nature) 162 180 unamortized share issue costs 265 396 non deductible reserves 165 1,291 13,698 16,213 14. Loans and borrowings January 1 Non current Loans (a) 1,694 Finance lease liabilities (b) 62 142 214 62 142 1,908 Current Loans (a) 1,611 2,469 Finance lease liabilities (b) 124 158 212 124 1,769 2,681 Total loans and borrowings 186 1,911 4,589 (a) Loans On July 25, 2008, in order to finance the Pet Protect acquisition, the Company entered into a three year loan agreement denominated in U.S. dollars for $7,098 with a recognised financial institution at a fixed interest rate of 4.52%. The security for the loan, provided by the Company, was the policy renewals on its U.S. book of business which is underwritten by Praetorian, the Company s U.S. insurance carrier. The terms of the loan restricted the Company from paying dividends other than to holders of the Company's Series I 6% convertible preferred shares. Payments occurred evenly over the course of the loan and commenced September 1, 2008. At,, the loan had a balance of U.S. dollars nil (, U.S. $1,605 or $1,597 in Canadian dollars, January 1, U.S. $3,810 or $3,988 in Canadian dollars). The Company entered into an agreement with Microsoft Canada Inc. to finance the acquisition of system and applications software and related support services that were delivered in February 2008. The principal amount financed was $450 at an effective interest rate of 8.5% and was repayable in 36 monthly instalments of $14 commencing February 1, 2008. At,, the loan had a balance outstanding of nil (, $14, January 1, $176). 28

Year ended, and, (b) Finance leases Lease liabilities are effectively secured as the rights to the leased assets revert to the lessor in the event of default. January 1 Gross finance lease liabilities Payments due no later than 1 year 133 173 239 Payments due later than 1 year but no later than 5 years 65 151 237 Payments due later than 5 years 198 324 476 Less future finance charges on finance leases (12) (24) (50) Present value of finance lease liabilities 186 300 426 The present value of finance lease liabilities is as follows: Due: January 1 No later than 1 year 124 158 212 Later than 1 year but no later than 5 years 62 142 214 Later than 5 years 186 300 426 During the twelve months ended,, $25 was expensed relating to the Company s operating leases (: $30). 15. Share capital January 1 Authorised: Unlimited preferred shares Unlimited common shares Issued: 4,875 preferred shares (, 4,875) 9,339 9,339 9,339 32,513 common shares (, 32,513) 5,158 5,158 5,111 14,497 14,497 14,450 On January 21, 2004, the Company completed a private placement financing of 5,000 Series I 6% convertible preferred shares of the Company ( preferred shares ) at a price of $2.00 per preferred share for aggregate gross proceeds to the Company of $10,000 and the net proceeds were $9,339 after deducting agent and issue costs. Each preferred share is entitled to cumulative dividends at a fixed rate of 6% payable annually on the anniversary date. Each preferred share is convertible into 1 common share in the capital of the Company at any time at the option of the holder. The Company may, at its option, redeem the convertible preference shares by providing 60 days written notice to the holders at a price of $2.15 per share. Subsequent to year end, on January 27, 2012, the Company declared and paid a dividend of $585 at $0.12 per share on 4,875 preferred shares outstanding at,, which has not been accrued at,. 29

Year ended, and, Share based payments Equity settled share based payments Common share options are granted to directors and selected employees of the Company. In accordance with the plan, the exercise price of the granted options is equal to the market price of the shares on the date of grant. Options granted under the plan typically vest annually over a three to five year period and are non transferable. The common shares issuable upon exercise of any option that is cancelled or terminated prior to its exercise will become available again for grant under the plan. Options granted under the plan may be exercised during a period not exceeding 10 years from the date of grant, subject to earlier termination if the option holder ceases to be an employee, officer or director of the Company. Movements in the number of share options outstanding and their related weighted average exercise prices are as follows: Year ended Number of Options Weighted average exercise price Number of Options Weighted average exercise price Options outstanding as at January 1 2,668 $1.60 3,511 $1.95 Granted 137 1.30 936 1.30 Forfeited (160) 1.43 (235) 1.79 Exercised (38) 1.37 Expired (385) 2.48 (1,506) 2.20 Options outstanding as at 2,260 $1.45 2,668 $1.60 Of the 2,260 outstanding options (, : 2,668 options), 1,240 options (, : 1,475 options) were exercisable. During the year ended,, no options were exercised (twelve months ended, : 38). During the year ended,, 137 options were granted compared to 936 options in the same period in the previous year. The weighted average fair value of options granted during the year ended, determined using the Black Scholes valuation model was $0.62 (, ; $0.62) per option. The significant inputs into the model were weighted average share price of $1.30 (, ; $1.30) at the grant date, volatility of 60% (, ; 60%), dividend yield of Nil, an expected option life of 4.15 years (, ; 4.5 years), and an annual risk free interest rate of 3.0% (, ; 3.0%). The volatility was determined using market inputs at the time of the options being granted. Deferred share based payments Under the share unit plan for directors, directors may elect to receive either cash or deferred share units ( DSU ) for their compensation. Following cessation of the function of director of the Company, a director can elect to receive a cash payment or common shares equal to the market value of the accumulated deferred share units. When a director elects to participate in 30

Year ended, and, this plan, the Company credits the full account of the director for the number of units equal to their deferred compensation divided by the fair value of the common shares at the date of grant to the cash option. As the director has the option of settling in cash or common shares the Company s DSUs are a compound financial instrument with a debt component, being the cash settlement option, and an equity component, being the equity settled option. In calculating the split between the debt and equity components, the Company first determines the fair value of the cash option and then secondly determines the fair value of the cash and equity option taken together and the difference between the two options is the fair value of the equity option. Under the terms of the Company s DSU plan, the debt liability at inception is equal to the combined fair value of the cash and equity option taken together and as such no value is assigned to the equity option. The variation in the fair value at each reporting period is recorded as a compensation expense with the counterpart in trade and other payables in the consolidated statement of financial position. Year ended Number of units: Balance, beginning of period 81 50 Directors compensation 46 34 Exercised/encashed (3) Balance, end of period 127 81 The expense recorded in the consolidated income statement relating to equity and deferred share based payments for the year ended, was $176 (, $59). During the year no amount was paid under the plan ( nil). The total number of common shares reserved under the Company s share based compensation plans is 4,547. The share unit plan for directors shall not exceed 1,000 of the total number of common shares reserved. 31

Year ended, and, 16. Expenses by nature Year ended Employee benefit expenses 10,835 9,943 Depreciation and amortisation 1,873 1,682 Advertising costs 4,901 7,310 Cost of goods sold 5,518 4,630 Information technology 683 634 Communications 1,576 1,567 Travel 367 338 Bank charges 1,099 1,024 Professional and legal fees 627 636 Rent 916 846 Bad debts 652 763 Foreign exchange (gain)/loss 160 (30) Other 779 757 29,986 30,100 16.1 Employee benefit expenses Year ended Wages and salaries 8,818 8,176 Share based payment charges 176 59 Social security costs 841 810 Bonuses 258 217 Defined contribution pension plan payments 36 42 Other Car, insurance premium payments, medical insurance payments 706 639 10,835 9,943 17. Finance income and costs The components of finance costs, net, include interest (expense) income and other finance costs as follows: 32 Year ended Interest income external sources 24 16 Interest income related party transactions 45 38 Interest expense on long term borrowings (28) (159) Net interest (expense) income 41 (105)

Year ended, and, 18. Earnings per share (a) Basic Basic earnings per share is calculated by dividing the profit attributable to equity holders of the Company by the weighted average number of common shares. Year ended Profit attributable to equity holders of the Company 2,827 2,423 After tax effect of dividends declared on preference shares (610) (610) Profit attributable to common equity holders of the Company 2,217 1,813 Weighted average number of common shares 32,513 32,497 Earnings per common share Basic 0.07 0.06 (b) Diluted Diluted earnings per share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of dilutive potential common shares: convertible preference shares, share options and deferred share units. The convertible preference shares are assumed to have been converted into common shares. For the share options, a calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average annual market share price of the Company s shares) based on the monetary value of the subscription rights attached to the outstanding share options. The number of shares calculated as above is compared with the number of shares that would have been issued assuming the exercise of the share options and the difference is diluted number of shares. For deferred share units, it is assumed that the balance will be settled in common shares. Year ended Profit attributable to equity holders of the Company 2,827 2,423 After tax effect of dividends declared on preference shares (610) (610) Profit attributable to common equity holders of the Company 2,217 1,813 Weighted average number of common shares 32,513 32,497 Adjustments assumed conversion of convertible preference shares 4,875 4,875 share options vested and in the money 41 387 assumed settlement of deferred share units in common 127 81 shares Weighted average number of common shares for diluted earnings per share 37,556 37,840 Earnings per common share Diluted 0.06 0.05 33

Year ended, and, 19. Business and geographical segments Business segments For management purposes, the Company is organized into two main operating segments insurance and non insurance. The insurance operations consist of the distribution and administration of the PetCare, Pet Protect, Petpals, ShelterCare, QuickCare, Cherryblue and other co branded, white labeled or private labeled pet insurance programs. The non insurance operations are made up of its 24PetWatch and Pet Protect pet registry and recovery service, the distribution of RFID microchip technology, the development and distribution of PetPoint, its animal shelter management software program and Petango.com, its on line pet portal which includes its on line adoptable search engine, thepetangostore.com and social networking. For segment reporting, certain costs are allocated to the reporting segments based on the resource usage of the two operating segments. Year ended, Insurance Non Insurance Cash and notes Consolidated receivable Revenue External Sales 22,263 10,911 33,174 Other 15 15 30 Total revenue 22,278 10,926 33,204 Profit (loss) before income tax 4,890 (1,631) 3,259 Profit (loss) for the period 4,511 (1,684) 2,827 Other information: Finance revenue 69 69 Finance costs (28) (28) Amortisation 765 1,108 1,873 Income tax 379 53 432 Capital asset additions and disposal 69 68 137 Intangible asset additions 60 2,662 2,722 Consolidated capital and intangible additions 129 2,730 2,859 Segment assets as at, 7,369 8,188 12,220 27,777 34

Year ended, and, Year ended, Insurance Non Insurance Cash and notes Consolidated receivable Revenue External Sales 23,430 8,778 32,208 Total revenue 23,430 8,778 32,208 Profit (loss) before income tax 5,311 (3,308) 2,003 Profit (loss) for the period 5,731 (3,308) 2,423 Other information: Finance revenue 54 54 Finance costs (159) (159) Amortisation 838 844 1,682 Income tax (420) (420) Capital asset additions 216 28 244 Intangible asset additions 66 2,842 2,908 Consolidated capital and intangible additions 282 2,870 3,152 Segment assets as at, 6,477 7,677 10,750 24,904 Segment assets as at January 1, 8,589 5,950 12,236 26,775 Geographic segments The Company s operations are located in Canada, the United States and the United Kingdom. Both the insurance and the noninsurance segments are located in each country. The following table provides an analysis of the Company s revenue geographically for each of the periods. Year ended United States 22,521 21,669 United Kingdom 4,520 4,565 Canada 6,163 5,974 33,204 32,208 35

Year ended, and, The following is an analysis of the carrying amount of segment assets, analyzed by the geographic area in which the assets are located:, United United States Kingdom Canada Consolidated Goodwill 3,609 40 3,649 Intangible assets 329 617 7,581 8,527 Property and equipment 50 37 859 946, United United States Kingdom Canada Consolidated Goodwill 3,544 40 3,584 Intangible assets 306 1,090 6,021 7,417 Property and equipment 51 47 941 1,039 January 1, United United States Kingdom Canada Consolidated Goodwill 3,865 40 3,905 Intangible assets 209 1,730 4,140 6,079 Property and equipment 54 52 968 1,074 No individual customer constitutes greater than 10% of the Company s revenues. The Company s results are not significantly impacted by seasonality. 20. Financial risk management 20.1 Financial risk factors The Company has financial assets and liabilities consisting of cash and cash equivalents, segregated cash, trade and other receivables, notes receivable, trade and other payables, due to insurance carriers and loans and borrowings. Loans and receivables are non derivative financial assets or liabilities with fixed or determinable payments that are not quoted in an active market. They are included in current assets or liabilities, except for settlements due greater than 12 months after the consolidated balance sheet date which are classified as non current assets or liabilities. The Company's financial assets and liabilities are recorded at their cost, or amortised cost when interest bearing, which approximates their fair value. The Company's financial assets and liabilities are exposed to certain financial risk factors including market risk (foreign exchange risk), credit risk and liquidity risk. (i) Market risk Foreign exchange risk Foreign exchange risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. 36

Year ended, and, The Company s consolidated statement of financial position is expressed in Canadian dollars but a portion of its business is conducted in U.S dollars and British pounds sterling. Changes in the exchange rates for such currencies into Canadian dollars can increase or decrease revenues, operating profit, earnings and the carrying values of assets and liabilities. The Company's U.S. and U.K. subsidiaries have local functional currencies, that is, U.S. dollars and British pounds sterling respectively. As such, the Company's exposure to currency fluctuations is limited to its net investment in the subsidiary. Foreign exchange translation gains and losses are calculated using the current method, that is, the rates in effect at each consolidated statement of financial position date. The foreign exchange translation gains or losses resulting from holding the net investment between the statement of financial position dates are recorded on the consolidated statement of financial position as other comprehensive income and are not reflected in the consolidated income statement until such time that the net investment is removed from the consolidated statement of financial position either through a sale or an impairment in value. On July 25, 2008, the Company borrowed U.S. $7,098 (CDN $7,256) to finance the acquisition of Pet Protect (note 14). The U.S. dollar denominated loan is a foreign currency transaction which does not form part of the foreign operation. As a result, the foreign exchange translation gains and losses which resulted from the relative change in the value of the exchange rate between the Canadian and U.S. dollar on the consolidated statements of financial position date as compared to the exchange rate at the beginning of the period are recorded on the consolidated income statement. The Company does not employ a foreign currency derivative hedging program and, therefore, foreign currency translations can have a significant impact on reported consolidated results during periods of fluctuating exchange rates. At,, the Company had the following financial assets and liabilities, denominated in U.S. dollars and U.K. Pound Sterling excluding inter company balances, which are eliminated on consolidation:, US Cash and cash equivalents 3,229 442 Trade and other receivables 1,010 41 Trade payables and accrued liabilities (1,769) (247) Borrowings Net financial asset exposure 2,470 236, US Cash and cash equivalents 2,211 309 Trade and other receivables 826 34 Trade payables and accrued liabilities (1,345) (214) Borrowings (1,605) Net financial asset exposure 87 129 As of,, a 10% appreciation or depreciation in the Canadian dollar at the consolidated statement of financial position date would have resulted in a decrease or increase in consolidated net income of approximately $246 (period ended, $20) as it relates to the above listed financial assets and liabilities. The Company is not exposed to price risk being the change in price of securities, and its exposure to changes in interest rates is not material. 37

Year ended, and, (ii) Credit risk: Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge its obligation. Total credit risk is $2.8 million (: $2.46 million) which includes trade and other receivables and notes receivable. (a) Trade receivables: The Company's trade receivables consist of credit extended to veterinary clinics and animal welfare organisations which arise primarily in connection with the sale of RFID microchips, and credit extended to individuals insured in connection with its individual insurance policy portfolio. As at, and, no individual veterinary clinic, animal welfare organisation or individual insured accounted for greater than 10% of the Company's trade receivables. The Company reviews individual credit balances for veterinary clinics and animal welfare organisations and sets reserves on a collective basis. The Company manages this portfolio of credits through a policy which restricts sales and shipments to any organisation which becomes more than 90 days past due. The Company manages its individual insured credit portfolio utilising an extensive communications program and sets reserves on a pooled basis. (b) Note receivable: The note is with a related party the Company's President and Chief Executive Officer. Management reviews the Company's collateral in place related to this note at each statement of financial position date to assess any value impairment. The Company maintains collateral, the fair value of which exceeds the fair value of the note receivable as described in note 8. (iii) Liquidity risk: Liquidity risk is the risk that the Company will encounter difficulty in meeting its obligations associated with financial liabilities. The Company monitors its cash flows on a continuous basis utilising financial projections to ensure that it can meet its financial obligations as they become due. Management expects to meet the below obligation through operating cash flows. 38

Year ended, and, The Company had the following financial commitments at, and at,. Less than 1 Between 1 Between 2 Over 5 years Total, year and 2 years and 5 years Trade and other payables 4,082 4,082 Due to insurance carriers 4,872 4,872 Borrowings (ex. finance lease obligations) Finance lease obligations 124 62 186 Operating lease obligations (including 871 1,580 1,934 490 4,875 premises leases) 9,949 1,642 1,934 490 14,015, Trade and other payables 3,093 3,093 Due to insurance carriers 4,193 4,193 Borrowings (ex. finance lease obligations) 1,637 1,637 Finance lease obligations 158 131 11 300 Operating lease obligations (including 874 1,617 2,210 928 5,629 premises leases) 9,955 1,748 2,221 928 14,852 20.2 Capital disclosures The Company has a capital management process in place to measure and monitor its available capital and assess its adequacy. The Company's objective when managing capital is to safeguard the Company's ability to continue as a going concern, so that it can continue to provide returns and benefits for its shareholders. The Company considers loans and borrowings and shareholders' equity, including convertible preferred shares net of its deficit, to form its capital base. The Company would consider increasing its capital base to take advantage of growth opportunities by issuing more shares or increasing its debt portfolio. Alternatively, the Company can reduce its capital by returning it to shareholders in the form of dividends. 21. Contingencies From time to time in connection with its operations, the Company is named as a defendant in actions for damages and costs allegedly sustained by the plaintiffs. While it is not possible to estimate the outcome of various proceedings at this time, such actions have generally been resolved with minimal damages or expense in excess of amounts provided and the Company does not believe that it will incur any significant additional loss or expense in connection with such actions. 22. Transition to IFRS The accounting policies set out in note 3 have been applied in preparing the financial statements for the year ended December 31, and the year ended, and in the preparation of an opening IFRS statement of financial position at January 1, (the Transition Date ). 39

Year ended, and, IFRS 1 requires first time adopters to retrospectively apply all effective IFRS standards as of the transition date, which for the Company is January 1,. However, it also provides for certain optional exemptions and certain mandatory exceptions for first time IFRS adopters. IFRS 1 also requires, on first time adoption, for the Company to make an explicit and unreserved statement of compliance. In preparing its opening IFRS statement of financial position, the Company has adjusted amounts reported previously in financial statements prepared in accordance with Canadian GAAP (its previous GAAP). An explanation of how the transition from previous GAAP to IFRS has affected the Company s financial position, financial performance and cash flows is set out in the following tables and the notes that accompany the tables. IFRS Exemption Options 1. Business combinations IFRS 1 provides the option to apply IFRS 3, Business Combinations, retrospectively or prospectively from the Transition Date. The retrospective basis would require restatement of all business combinations that occurred prior to the Transition Date. The Company elected not to retroactively apply IFRS 3 to business combinations that occurred prior to the Transition Date and such business combinations have not been restated. Any goodwill arising on such business combinations before the Transition Date has not been adjusted from the carrying value previously determined under Canadian GAAP as a result of applying this exemption. 2. Currency Translation Differences Retrospective application of IFRS would require the Company to determine cumulative currency translation differences in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates, from the date a subsidiary was formed or acquired. IFRS 1 permits cumulative translation gains and losses to be reset to zero at the Transition Date. The Company has elected to reset all cumulative translation gains and losses to nil and recognized all cumulative translation gains and losses, in opening retained earnings at the Transition Date. 3. Share based payments IFRS 2, Share Based Payments, encourages application of its provisions to equity instruments granted on or before November 7, 2002, but permits the application only to equity instruments granted after November 7, 2002 that had not vested by the Transition Date. The Company elected to apply the exemption provided under IFRS 1 and applied IFRS 2 for all equity instruments granted after November 7, 2002 that had not vested by the Transition Date. 4. Borrowing costs IAS 23, Borrowing Costs, requires an entity to capitalize the borrowing costs related to all qualifying assets for which the commencement date for capitalisation is the later of January 1, 2009 and the Transition Date or an earlier date chosen by the Company. A qualifying asset is an asset that necessarily takes a substantial period of time to get ready for its intended use or sale. The Company elected to apply IAS 23 as of the Transition Date and as such, all borrowing costs related to qualifying assets where the commencement date for capitalisation was prior to January 1, have been expensed. 40

Year ended, and, IFRS Mandatory Exemptions 1. Estimates Hindsight is not used to create or revise estimates. The estimates previously made by the Company under Canadian GAAP were not revised for application of IFRS. Reconciliations of Canadian GAAP to IFRS IFRS 1 requires an entity to reconcile equity, comprehensive income and cash flows for prior periods. The following represents the reconciliations from Canadian GAAP to IFRS for the respective periods noted for equity, earnings and comprehensive income: Reconciliation of Equity as at January 1 Shareholders equity under Canadian GAAP 15,546 14,244 Property and equipment and Intangible assets (32) (1) Other 9 Shareholders equity under IFRS 15,514 14,253 Reconciliation of profit for the year Year ended Net earnings under Canadian GAAP 2,355 Foreign currency translation adjustments 61 Share based compensation 7 Net profit under IFRS 2,423 (1) Impact of foreign exchange on property and equipment and intangible assets as a result of change in the functional currency of the US subsidiaries. Reconciliation of Comprehensive Income for the year Year ended Comprehensive income under Canadian GAAP 1,747 Differences in net earnings 68 Foreign currency translation adjustments (100) Comprehensive income under IFRS 1,715 41

Year ended, and, Changes in accounting policies 1. Foreign currency translation adjustment As stated in the section IFRS exemption options the Company applied the one time exemption to set the foreign currency cumulative translation adjustment ( CTA ) to zero as at January 1,. The cumulative translation adjustment balance as of January 1, of $1 was recognised as an adjustment to retained earnings. The application of the exemption had no impact on net equity. 2. Functional currency Management is required to make an assessment of each of its subsidiaries to determine each subsidiary s functional currency. In cases where the subsidiary s functional currency is the same as its parent company s, the parent company s exposure to foreign exchange movements is on a transactional basis, the same as it would be had the parent company completed the transactions directly itself. As a result, any gain or loss arising from currency movements is recorded in the income statement. Where the functional currency of the subsidiary is different from the parent company, the parent company s exposure to foreign exchange movements is limited to the parent s net investment in the subsidiary. As a result, any gains or losses arising from foreign exchange movements are recorded in the Consolidated Statement of Comprehensive Income under the heading foreign exchange differences on translating foreign operations. Under the latter scenario, a gain or loss is recorded in the statement of income only when realized upon the disposal of all or part of the subsidiary or the discontinuing of the subsidiary s operations. Canadian GAAP In assessing the functional currency of a subsidiary, Canadian GAAP requires management to review certain economic facts and circumstances including whether or not the reporting enterprises cash flows are insulated from any direct effects of the day to day operations of the subsidiary; whether sales prices for the foreign operation are determined by local competition or international pricing; whether the sales market for the foreign operation s products are primarily outside the reporting enterprises country or within it; whether labour, materials and other costs of the foreign operation s products are primarily local costs or whether they depend on products and services obtained from the country of the reporting enterprise; whether the day to day activities of the foreign operation are financed primarily from its own operations and local borrowings or primarily by the reporting enterprise or borrowings from the country of the reporting enterprise, and the extent of the interrelationship of the day to day activities of the foreign operation and the reporting enterprise. IFRS In assessing the functional currency of a subsidiary similar facts and circumstances are reviewed by management. However, unlike Canadian GAAP, IFRS divides facts and circumstances into primary indicators and secondary indicators with heavier emphasis given to those categorised as primary. Under IFRS, the primary indicators are (1) the currency that dominates the determination of sales prices and (2) the currency that most influences operating costs. All other facts and circumstances are considered secondary. 42

Year ended, and, Management s assessment of the functional currency of each of its subsidiaries at January 1, is as follows: Functional Currency Domicile Canadian GAAP IFRS PTZ Insurance Brokers Ltd. Canada Canadian Canadian Pethealth Services Inc. Canada Canadian Canadian PTZ Insurance Agency Ltd. US Canadian US Pethealth Services (USA) Inc. US Canadian US PetProtect Limited UK UK UK Pethealth Services (UK) Ltd. UK UK UK As stated in the section IFRS exemption options, the Company applied the one time exemption to set the foreign currency cumulative translation adjustment ( CTA ) to zero as of January 1,. As a result, all other adjustments relate to the impact of the change in functional currency of the Company s US subsidiaries after January 1,. 3. Share based compensation The Company has applied the IFRS 1 exemption and applied IFRS 2: (a) to equity instruments that were granted after November 7, 2002 that vest after the Transition Date; (b) to liabilities arising from cash settled share based payment transactions that will be settled after the Transition Date. The effect of the application of IFRS 2 are as follows: Recognition of expense Canadian GAAP For grants of share based awards with graded vesting, the total fair value of the award is recognized on a straight line basis over the employment period necessary to vest the award. IFRS Each tranche in an award with graded vesting is considered a separate grant with a different vesting date and fair value. Each grant is accounted for on that basis. As a result, the Company adjusted its expense for share based awards to reflect this difference in recognition. Forfeitures Canadian GAAP Forfeitures of awards are recognized as they occur. IFRS An estimate is required of the number of awards expected to vest, which is revised if subsequent information indicates that the actual forfeitures are likely to differ from the estimate. As a result, the Company adjusted its expense to reflect this difference. 43

Year ended, and, 4. Carrier cash and liabilities presented gross The Company maintains trust bank accounts on behalf of its carriers which are used to fund insurance claims when settled. Canadian GAAP The cash held in trust on behalf of a third party carrier and the corresponding liability were presented on a net basis. IFRS Amounts received on behalf of third parties should be accounted for as a payable in the statement of financial position until settled and should not gross up revenue and expenses. Similarly, amounts prepaid to third parties on behalf of customers should be recognized as a receivable until recovered and also should not gross up revenues and expenses Under IFRS, the Company has recorded cash held on behalf of its carriers as segregated cash and the liability to its carriers as Due to insurance carrier on a gross basis. The change in presentation is a reclassification on the statement of financial position and has no revenue or expense impact. 44

Reconciliation of Consolidated Statement of Financial Position as of January 1, (in thousands, except for EPS) Canadian GAAP accounts Canadian GAAP Balance IFRS Adjustments IFRS Reclassification IFRS Balance IFRS accounts ASSETS ASSETS Cash and cash equivalents 7,310 7,310 Cash and cash equivalents 3,489 3,489 Segregated cash Accounts receivable 2,245 2,245 Trade and other receivables Inventory 522 522 Inventory Prepaid expenses 714 714 Prepaid and other current assets Total current assets 10,791 3,489 14,280 Total current assets Notes receivable 1,437 1,437 Notes receivable Capital assets 1,074 1,074 Property and equipment Goodwill 3,905 3,905 Goodwill Intangible assets 6,079 6,079 Intangible and other assets Total non current assets 12,495 12,495 Total non current assets Total assets 23,286 3,489 26,775 Total assets Current liabilities Liabilities Accounts payable and accrued liabilities 4,226 (482) 3,744 Trade and other payables 482 482 Income taxes payable 3,489 3,489 Due to insurance carriers Deferred revenue 227 (9) 218 Unearned revenue Current portion of obligations 212 (212) under capital leases Current portion of long term debt 2,469 212 2,681 Loans and borrowings Current liabilities 7,134 3,480 10,614 Total current liabilities Obligations under capital leases 214 (214) Long term debt 1,694 214 1,908 Loans and borrowings Total non current liabilities 1,908 1,908 Total non current liabilities Total liabilities 9,042 3,480 12,522 Total liabilities Shareholders equity Equity Capital stock 14,450 14,450 Share capital Contributed surplus 1,533 77 1,610 Contributed surplus Accumulated other comprehensive loss (1,253) 1,253 Accumulated other comprehensive loss Deficit (486) (1,321) (1,807) Retained earnings (deficit) Total shareholders equity 14,244 9 14,253 Total Equity attributable to equity holders of the Company Total liabilities and shareholders equity 23,286 3,489 26,775 Total liabilities and equity 45

Reconciliation of Consolidated Income Statement for the year ended, (in thousands, except for EPS) Canadian GAAP accounts Canadian GAAP Balance IFRS Adjustments IFRS Reclassification IFRS Balance IFRS accounts Revenue Revenue Insurance commissions and fees 23,430-23,430 Insurance commissions and fees Microchip technology and noninsurance revenue 8,778-8,778 Microchip technology and noninsurance revenue Interest and other income 57 (57) 32,265 (57) 32,208 Expenses Employment 9,884 - (9,884) Marketing 7,309-5,104 12,413 Selling and marketing Selling, general and administrative 6,599-6,488 13,087 Administrative Cost of Sales 4,630 - - 4,630 Cost of goods sold Amortisation of capital & 1,683 (1,683) intangible assets Stock option and equity based compensation 68 (7) (61) Interest on long term debt 126 (126) Foreign exchange (gain)/loss 31 (61) - (30) Foreign exchange (gain)/loss Expenses 30,330 (68) (162) 30,100 Net income before income taxes 1,935 68 105 2,108 Results from operating activities (105) (105) Net finance revenue/(costs) Net income before income taxes 1,935 68-2,003 Profit before income tax Income tax expense/(recovery) (420) - - (420) Income tax expense Net Income 2,355 68-2,423 Profit for the period Dividends declared on preferred shares including dividend tax 610 - - 610 Included in consolidated statement for changes in equity Earnings per share Earnings per share Basic 0.05 0.01 0.06 Basic earnings per share Diluted 0.05 0.00 0.05 Diluted earnings per share 46

Reconciliation of Consolidated Statement of Comprehensive Income for the year ended, (in thousands, except for EPS) Canadian GAAP accounts Canadian GAAP Balance IFRS Adjustments IFRS Reclassification IFRS Balance IFRS accounts Net Income 2,355 68-2,423 Profit for the period Other comprehensive income (loss): Foreign currency translation adjustments (608) (100) - (708) Foreign currency translation differences for foreign operations Total Comprehensive income (loss) 1,747 (32) - 1,715 Total Comprehensive income (loss) 47

Reconciliation of Consolidated Statement of Financial Position as of, (in thousands, except for EPS) Canadian GAAP accounts Canadian GAAP Balance IFRS Adjustments IFRS Reclassification IFRS Balance IFRS accounts ASSETS ASSETS Cash and cash equivalents 5,082 5,082 Cash and cash equivalents 4,193 4,193 Segregated cash Accounts receivable 985-985 Trade and other receivables Inventory 154-154 Inventory Deferred income tax 168 - (168) Prepaid expenses 766-766 Prepaid and other current assets Total current assets 7,155 4,193 (168) 11,180 Total current assets Notes receivable 1,475-1,475 Notes receivable Capital assets 1,054 (15) 1,039 Property and equipment Goodwill 3,584-3,584 Goodwill Intangible assets 7,434 (17) 7,417 Intangible and other assets Deferred income tax 41-168 209 Total non current assets 13,588 (32) 168 13,724 Total non current assets Total assets 20,743 4,161 24,904 Total assets Current liabilities Liabilities Accounts payable and accrued liabilities 3,093-3,093 Trade and other payables Income taxes payable 4,193 4,193 Due to insurance carrier Deferred revenue 193 193 Unearned revenue Current portion of obligations 158 - (158) under capital leases Current portion of long term debt 1,611-158 1,769 Loans and borrowings Current liabilities 5,055 4,193 9,248 Total current liabilities Obligations under capital leases 142-142 Loans and borrowings Long term debt - Total non current liabilities 142 142 Total non current liabilities Total liabilities 5,197 4,193 9,390 Total liabilities Shareholders equity Equity Capital stock 14,497-14,497 Share capital Contributed surplus 1,651 68 1,719 Contributed surplus Accumulated other comprehensive loss (1,861) 1,153 (708) Accumulated other comprehensive loss Deficit 1,259 (1,253) 6 Retained earnings (deficit) Total shareholders equity 15,546 (32) 15,514 Total Equity attributable to equity holders of the Company Total liabilities and shareholders equity 20,743 4,161 24,904 Total liabilities and equity 48